BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright ©The Author(s) 2026.
World J Hepatol. Feb 27, 2026; 18(2): 113348
Published online Feb 27, 2026. doi: 10.4254/wjh.v18.i2.113348
Table 1 Demographics and laboratory findings among patients in the development cohort, n (%)
Characteristics
Total (n = 159)
Evident histological liver injury
P value
No (n = 87)
Yes (n = 72)
Demographic variables
Male115/159 (72.3)55/87 (63.2)60/72 (83.3)0.005
Age, year46.28 (10.84)42.98 (10.08)50.26 (10.44)< 0.001
Laboratory findings
    PLT, × 109/L167.87 (71.18)199.38 (59.86)129.81 (65.17)< 0.001
    ALT, U/L41.20 (59.35)27.69 (23.82)57.52 (81.59)0.001
    AST, U/L35.45 (36.51)24.56 (10.74)48.61 (50.06)< 0.001
    TP, g/L75.48 (5.01)75.56 (4.81)75.38 (5.27)0.83
    ALB, g/L46.46 (4.49)47.85 (3.49)44.79 (5.00)< 0.001
    TBIL, μmol/L16.91 (15.96)15.27 (18.97)18.90 (11.14)0.15
    DBIL, μmol/L6.19 (8.66)4.90 (8.96)7.76 (8.06)0.04
    HBV-DNA, × 105 IU/mL17.68 (135.71)31.04 (182.56)1.55 (11.71)0.17
    HBsAg, IU/mL1439.43 (6674.76)1938.84 (8631.85)835.98 (2867.01)0.30
    HBeAg, IU/mL93.11 (571.93)166.89 (767.11)3.95 (20.55)0.05
    HBcAb, IU/mL187.65 (313.01)222.54 (324.45)145.48 (295.34)0.12
Table 2 Univariable and multivariable logistic regression model for predicting development of evident histological liver injury in patients with chronic hepatitis B
FactorUnivariable analysis
Multivariable analysis
OR
95%CI
P value
OR
95%CI
P value
Male0.340.16-0.730.006
Age, year2.041.43-2.92< 0.001
L590.070.03-0.15< 0.0010.150.06-0.38< 0.001
PLT, × 109/L2.241.37-3.660.0012.711.09-6.750.03
ALT, U/L1.791.02-3.180.0487.201.35-28.80.02
AST, U/L5.562.14-14.47< 0.0018.401.10-63.80.04
ALB, g/L5.691.23-26.330.026
TBIL, μmol/L2.311.33-4.020.003
DBIL, μmol/L3.541.79-6.99< 0.001